| Product Code: ETC7539548 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India central nervous system therapeutic market import shipments exhibited a steady growth trend with a moderate CAGR from 2020 to 2024. Notably, there was a significant acceleration in growth from 2023 to 2024, indicating a strong upward momentum and expansion in the market during that period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Central Nervous System Therapeutic Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Central Nervous System Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 India Central Nervous System Therapeutic Market - Industry Life Cycle |
3.4 India Central Nervous System Therapeutic Market - Porter's Five Forces |
3.5 India Central Nervous System Therapeutic Market Revenues & Volume Share, By Disease, 2021 & 2031F |
4 India Central Nervous System Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of central nervous system disorders in India |
4.2.2 Growing awareness about mental health and neurological disorders |
4.2.3 Government initiatives to improve healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 High cost of CNS therapies leading to limited affordability for a large portion of the population |
4.3.2 Limited access to advanced diagnostic and treatment options in rural areas |
4.3.3 Stringent regulations and approval processes for CNS drugs in India |
5 India Central Nervous System Therapeutic Market Trends |
6 India Central Nervous System Therapeutic Market, By Types |
6.1 India Central Nervous System Therapeutic Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 India Central Nervous System Therapeutic Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 India Central Nervous System Therapeutic Market Revenues & Volume, By Neurovascular Diseases, 2021- 2031F |
6.1.4 India Central Nervous System Therapeutic Market Revenues & Volume, By CNS Trauma, 2021- 2031F |
6.1.5 India Central Nervous System Therapeutic Market Revenues & Volume, By Mental Health, 2021- 2031F |
6.1.6 India Central Nervous System Therapeutic Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.1.7 India Central Nervous System Therapeutic Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.8 India Central Nervous System Therapeutic Market Revenues & Volume, By CNS Cancer, 2021- 2031F |
7 India Central Nervous System Therapeutic Market Import-Export Trade Statistics |
7.1 India Central Nervous System Therapeutic Market Export to Major Countries |
7.2 India Central Nervous System Therapeutic Market Imports from Major Countries |
8 India Central Nervous System Therapeutic Market Key Performance Indicators |
8.1 Number of healthcare facilities offering CNS therapeutic services in India |
8.2 Percentage of population covered by health insurance that includes coverage for CNS treatments |
8.3 Investment in research and development of innovative CNS therapies in India |
9 India Central Nervous System Therapeutic Market - Opportunity Assessment |
9.1 India Central Nervous System Therapeutic Market Opportunity Assessment, By Disease, 2021 & 2031F |
10 India Central Nervous System Therapeutic Market - Competitive Landscape |
10.1 India Central Nervous System Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 India Central Nervous System Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here